C. Meylan et al., REVERSIBLE NEUTROPENIA DURING A COLD - POSSIBLE INVOLVEMENT OF RISPERIDONE - A CASE-REPORT, European neuropsychopharmacology, 5(1), 1995, pp. 1-2
After 9 days of risperidone therapy (2-6 mg/day), a 24-year-old schizo
phrenic female patient developed a leucopenia with neutropenia < 1000/
mm(3). A few days after starting the neuroleptic treatment, she suffer
ed from a cold, without fever. All immunological tests performed yield
ed negative results except for influenza B virus. The cessation of the
risperidone therapy was followed within 48 h by a normalisation of th
e WBC differential count. Therefore, in the absence of a rechallenge w
ith risperidone for ethical reasons, it cannot be excluded that risper
idone represents at least a partial cause of the observed neutropenia.